Clearwater Analytics to acquire Enfusion in $1.5 bln deal (updated)
13/01/2025 11:49
(Adds details throughout)
Jan 13 (Reuters) - Clearwater Analytics CWAN.N has
agreed to acquire investment management platform Enfusion
ENFN.N in a $1.5 billion cash-and-stock deal, the companies
said on Monday.
Enfusion shareholders will receive $5.85 in cash and $5.40
in Clearwater stock for each share, valuing the company at
$11.25 per share, a 13% premium to its last close.
Reuters had exclusively reported last year that
Chicago-based firm was
exploring options
including a sale.
J.P. Morgan Securities and Kirkland & Ellis advised
Clearwater Analytics, while Goldman Sachs and Dechert advised
Enfusion's special committee.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Anil
D'Silva and Vijay Kishore)
((ArasuKannagi.Basil@thomsonreuters.com;))